Latest Breaking News On - Janet qi - Page 1 : comparemela.com

PurMinds NeuroPharma Announces PUR501 as Lead Candidate Novel Non-Hallucinogenic Neuroplastogen

PurMinds NeuroPharma Appoints Vanessa Williamson as Chief Business Officer

Toronto, Ontario and Boston, Massachusetts (Newsfile Corp. - May 23, 2024) - PurMinds NeuroPharma ("PurMinds" or the "Company"), a clinical-stage neuroscience company focused on advancing a robust pipeline

The Best Advice I Ever Got On The Job

To commemorate Clinical Trials Day 2024, Clinical Leader tapped its community of clinical research professionals to share their insights — from.

PurMinds NeuroPharma Selected to Present at the 2024 OBIO Investment Summit

30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond - Enveric Biosciences (NASDAQ:ENVB), Cybin (AMEX:CYBN)

The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health conditions, this sector has attracted growing attention and investment.